United States Dasatinib Market Report 2017

August 2017 | 104 pages | ID: U439E900930EN
QYResearch

Abstracts

In this report, the United States Dasatinib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Dasatinib in these regions, from 2012 to 2022 (forecast).

United States Dasatinib market competition by top manufacturers/players, with Dasatinib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bristol-Myers Squibb
• Otsuka Pharmaceutical
• CTTQ PHARMA
• APOTEX INC

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 20 mg Tablets
• 50 mg Tablets
• 70 mg Tablets
• 80 mg Tablets
• 100 mg Tablets
• 140 mg Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dasatinib for each application, including

• Chronic Myelogenous Leukemia (CML)
• Philadelphia Chromosome-positive?Acute Lymphoblastic Leukemia(Ph+ ALL)
• Advanced Prostate Cancer

Contents

United States Dasatinib Market Report 2017

1 DASATINIB OVERVIEW

1.1 Product Overview and Scope of Dasatinib
1.2 Classification of Dasatinib by Product Category
  1.2.1 United States Dasatinib Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Dasatinib Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 20 mg Tablets
  1.2.4 50 mg Tablets
  1.2.5 70 mg Tablets
  1.2.6 80 mg Tablets
  1.2.7 100 mg Tablets
  1.2.8 140 mg Tablets
1.3 United States Dasatinib Market by Application/End Users
  1.3.1 United States Dasatinib Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Chronic Myelogenous Leukemia (CML)
  1.3.3 Philadelphia Chromosome-positive?Acute Lymphoblastic Leukemia(Ph+ ALL)
  1.3.4 Advanced Prostate Cancer
1.4 United States Dasatinib Market by Region
  1.4.1 United States Dasatinib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Dasatinib Status and Prospect (2012-2022)
  1.4.3 Southwest Dasatinib Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Dasatinib Status and Prospect (2012-2022)
  1.4.5 New England Dasatinib Status and Prospect (2012-2022)
  1.4.6 The South Dasatinib Status and Prospect (2012-2022)
  1.4.7 The Midwest Dasatinib Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Dasatinib (2012-2022)
  1.5.1 United States Dasatinib Sales and Growth Rate (2012-2022)
  1.5.2 United States Dasatinib Revenue and Growth Rate (2012-2022)

2 UNITED STATES DASATINIB MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Dasatinib Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Dasatinib Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Dasatinib Average Price by Players/Suppliers (2012-2017)
2.4 United States Dasatinib Market Competitive Situation and Trends
  2.4.1 United States Dasatinib Market Concentration Rate
  2.4.2 United States Dasatinib Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dasatinib Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DASATINIB SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Dasatinib Sales and Market Share by Region (2012-2017)
3.2 United States Dasatinib Revenue and Market Share by Region (2012-2017)
3.3 United States Dasatinib Price by Region (2012-2017)

4 UNITED STATES DASATINIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Dasatinib Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Dasatinib Revenue and Market Share by Type (2012-2017)
4.3 United States Dasatinib Price by Type (2012-2017)
4.4 United States Dasatinib Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DASATINIB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Dasatinib Sales and Market Share by Application (2012-2017)
5.2 United States Dasatinib Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DASATINIB PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bristol-Myers Squibb
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dasatinib Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bristol-Myers Squibb Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Otsuka Pharmaceutical
  6.2.2 Dasatinib Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Otsuka Pharmaceutical Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CTTQ PHARMA
  6.3.2 Dasatinib Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CTTQ PHARMA Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 APOTEX INC
  6.4.2 Dasatinib Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 APOTEX INC Dasatinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 DASATINIB MANUFACTURING COST ANALYSIS

7.1 Dasatinib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dasatinib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dasatinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dasatinib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DASATINIB MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Dasatinib Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Dasatinib Sales Volume Forecast by Type (2017-2022)
11.3 United States Dasatinib Sales Volume Forecast by Application (2017-2022)
11.4 United States Dasatinib Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Dasatinib
Figure United States Dasatinib Market Size (K Units) by Type (2012-2022)
Figure United States Dasatinib Sales Volume Market Share by Type (Product Category) in 2016
Figure 20 mg Tablets Product Picture
Figure 50 mg Tablets Product Picture
Figure 70 mg Tablets Product Picture
Figure 80 mg Tablets Product Picture
Figure 100 mg Tablets Product Picture
Figure 140 mg Tablets Product Picture
Figure United States Dasatinib Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Dasatinib by Application in 2016
Figure Chronic Myelogenous Leukemia (CML) Examples
Figure Philadelphia Chromosome-positive?Acute Lymphoblastic Leukemia(Ph+ ALL) Examples
Figure Advanced Prostate Cancer Examples
Figure United States Dasatinib Market Size (Million USD) by Region (2012-2022)
Figure The West Dasatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Dasatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Dasatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Dasatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Dasatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Dasatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dasatinib Sales (K Units) and Growth Rate (2012-2022)
Figure United States Dasatinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dasatinib Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Dasatinib Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Dasatinib Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dasatinib Sales Share by Players/Suppliers
Figure 2017 United States Dasatinib Sales Share by Players/Suppliers
Figure United States Dasatinib Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Dasatinib Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Dasatinib Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dasatinib Revenue Share by Players/Suppliers
Figure 2017 United States Dasatinib Revenue Share by Players/Suppliers
Table United States Market Dasatinib Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Dasatinib Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Dasatinib Market Share of Top 3 Players/Suppliers
Figure United States Dasatinib Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dasatinib Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dasatinib Product Category
Table United States Dasatinib Sales (K Units) by Region (2012-2017)
Table United States Dasatinib Sales Share by Region (2012-2017)
Figure United States Dasatinib Sales Share by Region (2012-2017)
Figure United States Dasatinib Sales Market Share by Region in 2016
Table United States Dasatinib Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Dasatinib Revenue Share by Region (2012-2017)
Figure United States Dasatinib Revenue Market Share by Region (2012-2017)
Figure United States Dasatinib Revenue Market Share by Region in 2016
Table United States Dasatinib Price (USD/Unit) by Region (2012-2017)
Table United States Dasatinib Sales (K Units) by Type (2012-2017)
Table United States Dasatinib Sales Share by Type (2012-2017)
Figure United States Dasatinib Sales Share by Type (2012-2017)
Figure United States Dasatinib Sales Market Share by Type in 2016
Table United States Dasatinib Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Dasatinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dasatinib by Type (2012-2017)
Figure Revenue Market Share of Dasatinib by Type in 2016
Table United States Dasatinib Price (USD/Unit) by Types (2012-2017)
Figure United States Dasatinib Sales Growth Rate by Type (2012-2017)
Table United States Dasatinib Sales (K Units) by Application (2012-2017)
Table United States Dasatinib Sales Market Share by Application (2012-2017)
Figure United States Dasatinib Sales Market Share by Application (2012-2017)
Figure United States Dasatinib Sales Market Share by Application in 2016
Table United States Dasatinib Sales Growth Rate by Application (2012-2017)
Figure United States Dasatinib Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Dasatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Dasatinib Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Dasatinib Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Dasatinib Revenue Market Share in United States (2012-2017)
Table Otsuka Pharmaceutical Basic Information List
Table Otsuka Pharmaceutical Dasatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Pharmaceutical Dasatinib Sales Growth Rate (2012-2017)
Figure Otsuka Pharmaceutical Dasatinib Sales Market Share in United States (2012-2017)
Figure Otsuka Pharmaceutical Dasatinib Revenue Market Share in United States (2012-2017)
Table CTTQ PHARMA Basic Information List
Table CTTQ PHARMA Dasatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CTTQ PHARMA Dasatinib Sales Growth Rate (2012-2017)
Figure CTTQ PHARMA Dasatinib Sales Market Share in United States (2012-2017)
Figure CTTQ PHARMA Dasatinib Revenue Market Share in United States (2012-2017)
Table APOTEX INC Basic Information List
Table APOTEX INC Dasatinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure APOTEX INC Dasatinib Sales Growth Rate (2012-2017)
Figure APOTEX INC Dasatinib Sales Market Share in United States (2012-2017)
Figure APOTEX INC Dasatinib Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dasatinib
Figure Manufacturing Process Analysis of Dasatinib
Figure Dasatinib Industrial Chain Analysis
Table Raw Materials Sources of Dasatinib Major Players/Suppliers in 2016
Table Major Buyers of Dasatinib
Table Distributors/Traders List
Figure United States Dasatinib Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Dasatinib Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Dasatinib Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Dasatinib Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Dasatinib Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Dasatinib Sales Volume (K Units) Forecast by Type in 2022
Table United States Dasatinib Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Dasatinib Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Dasatinib Sales Volume (K Units) Forecast by Application in 2022
Table United States Dasatinib Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Dasatinib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dasatinib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dasatinib Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources